Sonoda Hiroyuki, Sugimura Atsushi
Research Division, Medical Technology Research Center, JCR Pharmaceuticals Co, Ltd, Kobe, Japan.
Protein Expr Purif. 2008 Dec;62(2):153-9. doi: 10.1016/j.pep.2008.08.001. Epub 2008 Aug 14.
Vibriolysin, an extracellular protease of Vibrio proteolyticus, is synthesized as a preproenzyme. The N-terminal propeptide functions as an intramolecular chaperone and an inhibitor of the mature enzyme. Extracellular production of recombinant vibriolysin has been achieved in Bacillus subtilis, but not in Escherichia coli, which is widely used as a host for the production of recombinant proteins. Vibriolysin is expressed as an inactive form in E. coli possibly due to the inhibitory effect of the N-terminal propeptide. In this study, we isolated the novel vibriolysin engineered by in vivo random mutagenesis, which is expressed as active mature vibriolysin in E. coli. The Western blot analysis showed that the N-terminal propeptide of the engineered enzyme was processed and degraded, confirming that the propeptide inhibits the mature enzyme. Two mutations located within the engineered vibriolysin resulted in the substitution of stop codon for Trp at position 11 in the signal peptide and of Val for Ala at position 183 in the N-terminal propeptide (where position 1 is defined as the first methionine). It was found that the individual mutations are related to the enzyme activity. The novel vibriolysin was extracellularly overproduced in BL21(DE3) and purified from the culture supernatant by ion-exchange chromatography followed by hydrophobic-interaction chromatography, resulting in an overall yield of 2.2mg/L of purified protein. This suggests that the novel engineered vibriolysin is useful for overproduction in an E. coli expression system.
弧菌溶素是解蛋白弧菌的一种细胞外蛋白酶,最初以前原酶的形式合成。N端前肽发挥分子内伴侣和成熟酶抑制剂的作用。重组弧菌溶素已在枯草芽孢杆菌中实现细胞外生产,但在广泛用作重组蛋白生产宿主的大肠杆菌中却未能实现。弧菌溶素在大肠杆菌中以无活性形式表达,这可能是由于N端前肽的抑制作用。在本研究中,我们分离出了通过体内随机诱变改造的新型弧菌溶素,它在大肠杆菌中以活性成熟弧菌溶素的形式表达。蛋白质免疫印迹分析表明,改造后酶的N端前肽被加工和降解,证实了前肽对成熟酶具有抑制作用。改造后的弧菌溶素中有两个突变,导致信号肽第11位的色氨酸被终止密码子取代,N端前肽第183位的丙氨酸被缬氨酸取代(其中第1位定义为第一个甲硫氨酸)。研究发现,单个突变与酶活性有关。新型弧菌溶素在BL21(DE3)中细胞外过量表达,并通过离子交换色谱随后进行疏水相互作用色谱从培养上清液中纯化,纯化蛋白的总产率为2.2mg/L。这表明新型改造后的弧菌溶素对于在大肠杆菌表达系统中过量生产是有用的。